GlassScriptPhysician profile
Arash Samarghandi
NPI 1326489972
$19,215.49
in general payments reported to CMS, 2019-2025
35 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.38 · 2021: $743 · 2022: $1,146 · 2023: $1,321 · 2024: $2,299 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,600 · Food and Beverage: $7,250 · Travel and Lodging: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,599.99 |
| Food and Beverage | $7,250.15 |
| Travel and Lodging | $1,460.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,259.66 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,720.43 | 2020-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $1,643.17 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $793.44 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| Genzyme Corporation | $632.75 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $538.55 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $440.04 | 2022-2025 | Acthar |
| Abbvie INC. | $393.78 | 2021-2025 | Avycaz, Teflaro |
| Actelion Pharmaceuticals US, INC. | $383.41 | 2022-2024 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $321.74 | 2021-2025 | Dupixent |
| Inspire Medical Systems, INC. | $251.04 | 2023-2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $215.86 | 2023-2025 | Glassia |
| Merck Sharp & Dohme LLC | $197.63 | 2022-2025 | Zerbaxa, Recarbrio |
| Insmed, INC. | $183.04 | 2023-2025 | Arikayce, Brinsupri |
| Pfizer INC. | $167.90 | 2021-2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $163.06 | 2024 | Yupelri |
| Verona Pharma, INC. | $149.63 | 2025 | Ohtuvayre |
| Electromed, INC. | $148.74 | 2024-2025 | Smartvest |
| Ambu INC. | $109.80 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.93 | 2022-2023 | |
| United Therapeutics Corporation | $59.29 | 2022-2025 | Tyvaso |
| Amgen INC. | $46.63 | 2024-2025 | Tezspire |
| 3b Medical, INC. | $45.49 | 2024-2025 | Luna |
| Astellas Pharma US INC | $43.70 | 2021-2022 | |
| Inari Medical, INC. | $35.33 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Viatris Specialty LLC | $27.13 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $26.24 | 2025 | Sunosi |
| Vapotherm INC | $23.62 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.45 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $22.51 | 2025 | Lumryz |
| Grifols USA, LLC | $22.22 | 2025 | Prolastin-C Liquid |
| Livanova USA, INC. | $18.50 | 2022 | |
| Genentech USA, INC. | $17.96 | 2022 | |
| Philips North America LLC | $13.53 | 2025 | Vest Therapy Und |
| Itamar Medical INC | $12.29 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Samarghandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.